VEEV
Veeva Systems Inc.

Veeva Systems Inc.VEEV

Healthcare · Health Information Services
234.69USD
+1.83%
Sep 23, 2026
VEEV overview ready
Life-Sciences Vertical Software Unifying Cloud Workflows with Embedded AI
Veeva is a life-sciences vertical-software pure play.
Narrative not measured
Life Sciences Digitalization and Compliance ModernizationRegulated Life-Sciences Workflow and Data PlatformsPure play
Advancing price action
Longer-term context reads early trend, with a near-term setup of daily reclaim.
Demanding valuation
Veeva Systems Inc. carries a Expensive valuation stance that the scored components do not clearly support.
Unremarkable fundamentals
Primary risk
Dependence on continued adoption of cloud solutions in regulated life sciences.
Market Aug 10Filing Jul 31Price action Aug 9Research Jul 29

Conviction Level

NarrativeHeatThemeHeat6.7PriceAction8.6Valuation3.1CompanyPosition9.3
Price
Loading price history…

Price Action

Advancing price action
Longer-term context reads early trend, with a near-term setup of daily reclaim.
EntryBreakout + retest

Price broke through the weekly SMA200, then retested it constructively and recovered — a fresh structural entry rather than a chase.

Key Financials

Market Cap
$38.0B
Avg Volume (60D)
2.1M
60 sessions
Revenue Growth YoY
+16.3%
FY2026 vs FY2025
Gross Margin
+75.0%
Trailing twelve months
Operating Margin
+29.9%
Trailing twelve months
Free Cash Flow Yield
+3.3%
P/E
37.4x
Market metrics as of Aug 10, 2026
Financial results for the period ended Jul 31, 2026
Filed balance-sheet data as of Jul 31, 2026

Fundamentals & Valuation

One of the two valuation perspectives says expensive; intrinsic is the dissenting view.
Veeva Systems Inc. carries a Expensive valuation stance that the scored components do not clearly support. Treat it as unresolved.

Company Research

Thesis
Veeva is a life-sciences vertical-software pure play. Its industry cloud spans Development, Quality, Commercial, and Data Cloud products, with a current commercial migration cycle toward Vault CRM and expanding embedded AI capabilities.
Opportunity
Moderate opportunity
Biopharma and medtech spending on purpose-built cloud platforms that unify clinical development, regulatory, quality, safety, medical, and commercial workflows while maintaining auditability, controlled content, and industry-specific data governance.
Key risk
Dependence on continued adoption of cloud solutions in regulated life sciences.

Narrative & Theme

Life Sciences Digitalization and Compliance Modernization
Part of Regulated Life-Sciences Workflow and Data Platforms, with strong fit.
VEEV has a genuine, direct exposure to a distinct life-sciences software modernization narrative rather than to the approved cybersecurity narrative.
Narrative HeatNeutral4.9 / 10
This reading is no longer current (last measured 2026-08-14). It is kept until the next scheduled measurement replaces it.
Theme HeatNeutral6.7 / 10
This is the company’s own research reading. The canonical heat measurement for this story has not run.

Business & Markets

Healthcare · Health Information Services
What they do

Veeva Systems Inc. provides cloud-based software solutions tailored for the life sciences industry, enabling pharmaceutical and biotechnology companies to manage commercial, medical, and regulatory data across multiple regions globally.

How it earns

The company primarily generates revenue through subscription-based licensing of its cloud software platforms.

Products & services
Veeva Vault CRM Suite
Veeva Medical
Veeva PromoMats
Veeva Crossix
Veeva Data Cloud
Customers & end markets
Pharmaceutical companies
Biotechnology companies
Market position

Leader in cloud software solutions for the life sciences industry.

Demand drivers
Low cyclicality

Demand is driven by ongoing regulatory and commercial needs in healthcare, which are relatively stable and less sensitive to economic cycles.